Strength biowaiver [Dissolution / BCS / IVIVC]

posted by Helmut Homepage – Vienna, Austria, 2018-02-25 14:20 (3037 d 18:18 ago) – Posting: # 18461
Views: 6,343

Hi powell,

I suggest:
  1. Cardot J-M, García-Arieta A, Paixão P, Taševská I, Davit B. Implementing the Biopharmaceutics Classification System in Drug Development: Reconciling Similarities, Differences, and Shared Challenges in the EMA and US-FDA-Recommended Approaches. AAPS J. 2016;18(4):1039–46. doi:10.1208/s12248-016-9915-0.
  2. Cardot J-M, García-Arieta A, Paixão P, Taševská I, Davit B. Implementing the additional strength bio­waiver for generics: EMA recommended approaches and challenges for a US-FDA submission. Eur J Pharm Sci. 2018;111:399–408. doi:10.1016/j.ejps.2017.10.013.
Both papers contain case studies.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
170 visitors (0 registered, 170 guests [including 18 identified bots]).
Forum time: 09:39 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5